JPS6399007A - 徐放性薬剤配合物の製造方法 - Google Patents

徐放性薬剤配合物の製造方法

Info

Publication number
JPS6399007A
JPS6399007A JP62244416A JP24441687A JPS6399007A JP S6399007 A JPS6399007 A JP S6399007A JP 62244416 A JP62244416 A JP 62244416A JP 24441687 A JP24441687 A JP 24441687A JP S6399007 A JPS6399007 A JP S6399007A
Authority
JP
Japan
Prior art keywords
drug
formulation
sustained release
mixture
benzodiazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62244416A
Other languages
English (en)
Japanese (ja)
Other versions
JPH03363B2 (OSRAM
Inventor
プラブヘイカー・ランチホーダス・シス
ジヤツク・レボン・トソウニヤン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS6399007A publication Critical patent/JPS6399007A/ja
Publication of JPH03363B2 publication Critical patent/JPH03363B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP62244416A 1975-03-17 1987-09-30 徐放性薬剤配合物の製造方法 Granted JPS6399007A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US658003 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation
US559107 1990-07-27

Publications (2)

Publication Number Publication Date
JPS6399007A true JPS6399007A (ja) 1988-04-30
JPH03363B2 JPH03363B2 (OSRAM) 1991-01-07

Family

ID=26625891

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62244416A Granted JPS6399007A (ja) 1975-03-17 1987-09-30 徐放性薬剤配合物の製造方法

Country Status (5)

Country Link
JP (1) JPS6399007A (OSRAM)
KR (1) KR800001387B1 (OSRAM)
BE (1) BE839604A (OSRAM)
FI (1) FI760702A7 (OSRAM)
ZA (1) ZA761305B (OSRAM)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005531531A (ja) * 2002-04-15 2005-10-20 パリス，ローレンス 徐放性軟カプセル剤用の液体組成物およびこれらの製造方法
JP2008530175A (ja) * 2005-02-16 2008-08-07 ソルヴェイ（ソシエテ アノニム） 生物学的活性物質と、炭酸カルシウム含有賦形剤とを含む錠剤
JP2015533139A (ja) * 2012-10-12 2015-11-19 オムヤ インターナショナル アーゲー 官能化された炭酸カルシウムを用いた胃内滞留性薬物製剤および送達系ならびにその調製方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005531531A (ja) * 2002-04-15 2005-10-20 パリス，ローレンス 徐放性軟カプセル剤用の液体組成物およびこれらの製造方法
JP4918212B2 (ja) * 2002-04-15 2012-04-18 パリス，ローレンス 徐放性軟カプセル剤用の液体組成物およびこれらの製造方法
JP2008530175A (ja) * 2005-02-16 2008-08-07 ソルヴェイ（ソシエテ アノニム） 生物学的活性物質と、炭酸カルシウム含有賦形剤とを含む錠剤
JP2015533139A (ja) * 2012-10-12 2015-11-19 オムヤ インターナショナル アーゲー 官能化された炭酸カルシウムを用いた胃内滞留性薬物製剤および送達系ならびにその調製方法

Also Published As

Publication number Publication date
FI760702A7 (OSRAM) 1976-09-18
BE839604A (fr) 1976-09-16
JPH03363B2 (OSRAM) 1991-01-07
KR800001387B1 (en) 1980-11-26
ZA761305B (en) 1977-02-23

Similar Documents

Publication Publication Date Title
US4167558A (en) Novel sustained release tablet formulations
US4140755A (en) Sustained release tablet formulations
US4126672A (en) Sustained release pharmaceutical capsules
JPS638084B2 (OSRAM)
US4424235A (en) Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
US5232704A (en) Sustained release, bilayer buoyant dosage form
US4814179A (en) Floating sustained release therapeutic compositions
Gopalakrishnan et al. Floating drug delivery systems: a review
CA2451106C (en) Sequential drug delivery systems
JP2509226B2 (ja) ニトロフラントイン投薬型
CA2182004C (en) Film coated tablet of paracetamol and domperidone
JPS61178916A (ja) 治療的に有効な固体ユニツト投薬フオ−ムの製造方法
JPH0669965B2 (ja) 固体持続放出医薬製剤
WO2005079384A2 (en) Expandable gastric retention device
GB2105590A (en) Flotable controlled release preparations
US4814178A (en) Floating sustained release therapeutic compositions
JPH0625064B2 (ja) 制御放出塩化カリウム
WO2003015745A1 (en) Expandable gastric retention device
JPS6399007A (ja) 徐放性薬剤配合物の製造方法
Naval Formulation and evaluation of floating microspheres of captopril for prolonged gastric residence time
Janhavi et al. A Comprehensive Review on Gastro-Retentive Floating Drug Delivery Systems
US4681756A (en) Prevention of N-nitroso compound formation in vivo
Gurnany et al. Gastro Retentive Drug Delivery System-A Review
JPH0747534B2 (ja) 錠 剤
GB2097676A (en) Pharmaceutical composition for prevention of formation of N-nitroso compounds